Why NAD+ Matters
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell in your body, playing a central role in energy metabolism, DNA repair, and cellular stress responses. NAD+ levels decline significantly with age — by some estimates, levels at 50 are roughly half those at 20 — and this decline has been linked to mitochondrial dysfunction, metabolic disease, and accelerated aging in animal models.
The question driving the NMN and NR supplement market: can you meaningfully raise NAD+ levels in humans by taking a precursor orally, and does doing so produce real health benefits?
The short answer: yes to the first question, uncertain to the second.
What Are NMN and NR?
Both are precursors in the NAD+ biosynthesis pathway — meaning your cells convert them into NAD+ after absorption. They differ in their position on that pathway:
- NR (Nicotinamide Riboside) — one step upstream from NMN. Absorbed by cells, converted to NMN, then to NAD+
- NMN (Nicotinamide Mononucleotide) — one step closer to NAD+ in the pathway. Recent research suggests it may be absorbed more directly via a dedicated intestinal transporter (Slc12a8), though this is still debated
Both supplements enter the pathway at different points but converge on the same endpoint. Neither goes directly to NAD+ — your cells do the final conversion.
Head-to-Head: NMN vs NR
The Human Trial Evidence
NR — More Published Data
NR has been studied in humans since 2016. A foundational study by Martens et al. (2018, Nature Communications) gave 120 healthy older adults 500 mg/day NR for 6 weeks. Results: blood NAD+ rose ~60%, with no significant adverse effects. Skeletal muscle NAD+ also increased — an important finding given that muscle is where many aging-related energy deficits occur.
Subsequent trials have explored NR in specific populations:
- Cardiovascular health — NR improved aortic stiffness markers and blood pressure in older adults in a small RCT (Dolopikou et al., 2020)
- Metabolic function — Mixed results. Some trials show improvements in insulin sensitivity; others find no effect on metabolic markers
- Cognitive function — A 2023 trial in mild cognitive impairment showed NR improved cognition scores vs. placebo, though the sample was small
- Exercise performance — No consistent benefit in healthy young adults at typical doses
NMN — Catching Up Fast
NMN research in humans has accelerated since 2020. A landmark Japanese RCT (Irie et al., 2020) gave 10 healthy men 100, 250, or 500 mg NMN as a single oral dose. Blood NMN levels rose dose-dependently, blood NAD+ metabolites increased, and no adverse effects were observed — establishing oral NMN is safe and bioavailable.
A larger trial by Yi et al. (2023) — currently the most cited NMN human study — randomized 80 middle-aged adults to 300 or 600 mg/day NMN for 60 days. Results:
- NAD+ levels increased significantly in both groups
- Muscle strength and physical performance improved in the 300 mg group
- Telomere length — a marker of cellular aging — increased vs. placebo
- No serious adverse effects reported
Key Differences That Actually Matter
| Factor | NMN | NR |
|---|---|---|
| Evidence volume | Growing rapidly (~8 RCTs) | More established (~15+ RCTs) |
| Cost per effective dose | Higher ($1–3/day) | Lower ($0.50–1.50/day) |
| Blood NAD+ raise | Comparable (~40–90%) | Comparable (~40–90%) |
| Tissue specificity | May favor muscle via Slc12a8 | Broadly distributed |
| Stability | Less stable; degrade faster | More stable in formulation |
| Safety profile | Good (short-term) | Good (short-term) |
| Long-term human data | Limited (<12 months) | Limited (<12 months) |
The Sublingual NMN Argument
Some NMN proponents argue that sublingual (under-the-tongue) delivery bypasses the gut conversion of NMN to NR that may occur during digestion, allowing NMN to enter the bloodstream intact. A 2022 study by Okabe et al. compared oral and sublingual NMN and found sublingual delivery did produce higher peak blood NMN levels.
Whether higher blood NMN (vs. NR) translates to better outcomes is unknown. Until more tissue-level data exists in humans, sublingual delivery is an interesting hypothesis, not an established advantage.
Who Should Consider Each
NR May Be the Better Choice If You:
- Want more published human evidence per dollar spent
- Are new to NAD+ supplementation and want to start with the better-studied option
- Have a limited supplement budget
- Are primarily interested in cardiovascular or metabolic health outcomes
NMN May Be Worth Considering If You:
- Are following a longevity protocol based on Sinclair or similar frameworks
- Are specifically interested in muscle performance or physical aging markers
- Have already tried NR without noticeable effect and want to experiment
- Budget is not a primary constraint
What to Look for in a Product
Purity and third-party testing are critical in this category — some NMN products have been found to contain less active ingredient than labeled. Look for:
- Certificate of Analysis (COA) from an independent lab
- Stated purity ≥ 98% for NMN; ≥ 99% is achievable and common in reputable brands
- Niagen® for NR — the only patented, clinically-studied NR form with extensive published safety data
- Dosing that matches research: 250–500 mg NMN, 300–500 mg NR per daily serving
Safety Considerations
Both NMN and NR have acceptable short-term safety profiles in the doses studied. Key considerations:
- Cancer history — NAD+ is a fuel for cellular energy production in all cells, including cancer cells. Individuals with active cancer or a history of certain cancers should discuss NAD+ supplementation with their oncologist before starting
- Long-term data — most human trials run 8–12 weeks. Long-term (multi-year) safety data does not yet exist for either compound in humans
- Drug interactions — limited data; no major known interactions, but NMN may interact with some chemotherapy agents (theoretical)
- Pregnancy / breastfeeding — insufficient safety data; avoid during these periods
🔍 Check Your Full Longevity Stack
Adding NMN or NR is rarely the only supplement in a longevity-focused stack. Use PickScope's AI Stack Auditor to check for interactions, duplicated mechanisms, and missing co-factors across everything you're taking — including resveratrol, berberine, and metformin combinations that commonly appear alongside NAD+ precursors.
Run a Free Stack Audit →The Bottom Line
The science on NMN and NR is legitimately exciting — unlike many supplement categories, there are real human trials showing real effects on NAD+ metabolism, and early signals on muscle function and aging markers. The honest summary: both work for raising NAD+, the clinical outcomes in healthy humans are still being established, and neither is likely to be transformative in isolation.
If you're going to take one, NR at 300–500 mg/day offers the best combination of published evidence, product quality options, and cost. NMN at 250–500 mg/day is a reasonable alternative — particularly if muscle performance or physical aging markers are your primary interest, or if you want to track the rapidly evolving research in this space.
Either way, verify the product purity, set realistic expectations, and use PickScope to make sure your full stack makes sense together.